Archive for September, 2010

pharmaceutical and biopharmaceutical industry in an environment experiencing a dramatic escalation of costs for R & D, expiration of important patents filed, and continued high failure rate for new molecules in development.

In response, pharmaceutical companies to broaden the need, the range of ideas for their creative research process to enhance their drug discovery pipelines recognized. Therefore, the industry has sought to develop external collaborations not only with other companies, but also improve more with universities to provide access to new technologies for their drug discovery and candidate development license. In fact, the cooperation an essential part of today’s efforts in drug discovery, and often with multiple partners in any process, often iterative, continuous and long-term, which generates made supplements to the complexity of managing effectively both cooperation itself and the data .

This report examines the opportunities and challenges through cooperation with researchers from the University and the identification of key inputs from both industrial and academic partners presented. Different cultures and organizational structures are reviewed, and consideration of the objectives of each institution and the challenges that produce them. The report examines the various types of agreements that can be used, the importance of legislation underscores to ensure adequate protection of intellectual property and provides case studies of well-known collaborations addition, the report Reflections offers about future cooperation agreements and the benefits they bring to both parties.

main features of the report

• Describes the various types of cooperation between universities and pharmaceutical / biopharmaceutical industry, cultural aspects and organizational conflict through these forms of cooperation and management presented processes necessary to meet these challenges.
• Notice of the international and national legislation on intellectual property rights for the owners of Technology (University) and partners for technology transfer that technology (pharmaceutical industry) is to use ..
• Identifies a variety of different partnerships, and these groups into two main categories
• Provides a series of case studies, the main characteristics of this cooperation, the practical implications and the complexity of the agreements, and the pitfalls encountered in some cases.
• Focuses on the transformation of the cooperation between the pharmaceutical industry and academic institutions, development of new issues and opportunities for drug discovery through new collaborative models and approaches.

Key Benefits Report

• Provides executive with an overview of the complex nature of the problems and challenges facing universities and industry to the terms of a cooperation agreement to create problems with the differences in management styles and cultures of the various parties in the collaboration.
• Describes the methods used to identify a suitable candidate for co-operation and helps the reader understand the factors that influence partner selection and dynamics of the emerging network.
• Highlights problems with the transfer of knowledge and technology between the partners and the common challenges before companies are able to exploit new technologies.
• Identifies and describes the various emerging virtual institutions such as research clusters that take advantage of developments in communication technology.
• Provides an overview on the future of university-industry cooperation and the importance of information and communication technology can have on the development of the next generation of collaborative partnerships. have

Highlights

While academic institutions tried to stay true to the principles of free inquiry and intellectual freedom, political forces of economic globalization as an increasingly conservative agenda, a strengthening of public financial support for universities and their changing role in society led to the emergence of corporate universities and entrepreneurship.

The traditional view that there is separation between the “ivory tower” academic science base and more commercial applied research and development in the industry now obsolete. Instead, there was a considerable synergy between basic research in academic and applied research that is conducted in the pharmaceutical industry performed.

Major collaborations have can take into account a wide range of stakeholders, and failure to include all views, a strong opposition that can ultimately undermine the value of the partnership for both parties. Both the precise terms of the agreement and the presentation of these conditions for all the community are critical to successful collaboration.

Key questions answered in this report

What are the main factors affecting change towards a more collaborative approach to R & D in the pharmaceutical industry • What are the latest developments in the collaborative approach to R & D models that represent the best opportunities are, for the pharmaceutical industry.
• What are the issues and concerns on the development of collaborative R & D paradigms?
• What are the issues of intellectual property management should be considered by each are parties?
• What changes in patent law are highly relevant to the formation of partnerships in different countries?
• What are the different types of cooperation between universities and companies?
• What are the advantages and disadvantages of each party collaborations between universities and industry?
• What are the critical success factors for collaboration between universities and companies?
• What are the main factors to be considered in the negotiation of university-industry partnerships?
• What the management of cultural change and the challenges in aligning goals?
• What are the future cooperation between science and industry more information on this report and purchase a copy, visit:
http://www.visionshopsters.com/product/6006 / Drug Discovery Collaborations between Academia-and-the-pharmaceutical industry and culture, factors of intellectual property considerations, case studies, and future-trends.html

Contact us:

Vision Shop Planters
Tel: 91-22-40583020
EMAILID: marketing@visionshopsters.com
Site: www. visionshopsters.com

Review of intellectual property